Ekso Bionics (EKSO)
(Delayed Data from NSDQ)
$1.16 USD
-0.01 (-0.43%)
Updated Sep 10, 2024 10:29 AM ET
2-Buy of 5 2
D Value B Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Ekso Bionics Holdings, Inc. [EKSO]
Reports for Purchase
Showing records 1 - 20 ( 35 total )
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Strong Q2 With Initial CMS Claims Submitted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Favorable Reimbursement Decision to Drive Growth in 2H24 and Beyond; Higher PT $10; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Positive Revenue Trend Expected to Continue; New $9.25 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Strong 2023 Exit Bodes Well For 2024; New PT $10; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Another Strong Quarter for Ekso Health; Indego Personal Gaining Momentum; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Strong 1Q23 Results Bode Well for Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Indego Acquisition to Aid in Sustainable Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Steady Revenue Growth Continues; Adjusting PT to $9.00; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Growth on the Horizon in 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
2021 Growth Bodes Well for 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Preliminary 4Q21 Results Bode Well For 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
EksoHealth Growth Momentum Continues; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Subscription Model Aiding Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Signs of Success With New Commercial Model; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Subscription-Based Service Model Bodes Well for Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ekso Bionics Holdings, Inc.
Industry: Medical - Instruments
Recovery Continues; EVO Launch Could Add to Growth; Adjusting PT to $11; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S